FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma
RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food […]
THURSDAY, Nov. 8, 2018 — A new version of an over-the-counter asthma inhaler that was taken off the market in […]Mist
FDA Approves New Version of OTC Primatene Mist